Key diabetes drug to cost up to 90% less in a few days | India News – The Times of India
NEW DELHI: Several domestic drug companies are set to transform diabetes therapy by launching the blockbuster drug Empagliflozin at a fraction of the innovator’s price.Affordable generics will hit the market within days, following the expiry of Boehringer Ingelheim’s patent on Empagliflozin on March 11, industry sources told TOI.The launch of generic Empagliflozin, used to treat…